Effect of tubule-specific LincRNA-p21 KO on biometabolic parameters in mice
(A) Changes in BW over the experimental period. LincRNA-p21 KO did not alter BW (B), blood glucose (C), serum triglyceride (D), and cholesterol (E) after 8 weeks of HFD. (F–H) LincRNA-p21 KO significantly reduced sCr (F), BUN (G), and urinary albumin level (H) after 8 weeks of HFD. Data are mean ± SEM from each group (n ≥ 5); ∗p < 0.05; NS, statistically not significant.